Last updated: September 8, 2026, 12:25 pm
Last updated: September 8, 2026, 12:25 pm
SAAP-04 - FIP IPS Industrial Innovation Summit (supported by US Pharmacopeia)
Tracks
Room 522-A
| Saturday, August 29, 2026 |
| 9:00 AM - 5:00 PM |
Details
Organised by the FIP Industrial Pharmacy Section
Chair:
Mr. Mustafa Abacioglu, FIP Industrial Pharmacy Section Executive Committee Member, Turkiye/USA
Introduction:
The FIP IPS x US Pharmacopeia - Industrial Innovation Summit brings together global leaders across the industry to highlight the essential role of industrial pharmacy in advancing patient-centred care and global health. Under the theme βOne Health, One Pharmacy, One Industry β United in Innovation,β the summit will explore how industry-driven innovation strengthens resilient health systems, enhances access to high-quality medicines, and supports the One Health agenda.
Through focused discussions on manufacturing science, digital transformation, regulatory pathways, and cross-sector collaboration, participants will examine how industrial pharmacy bridges science, practice, and education. Join us as we set the stage for a more integrated and innovative future for pharmacy at the FIP World Congress in Montreal.
Programme:
Registration Fees:
The session is accessible with pre-registration only via the regular congress registration.
FIP Members: 140 Euros
Non-Members: 190 Euros
Early Career Pharmacists (ECPG Members): 110 Euros
| 09:00 β 09:30 | Welcoming and network |
| 09:30 β 10:15 | Pharma 4.0β’: Updates on the latest use of Artificial Intelligence & Machine Learning |
| Dennis Hall, MBA β Vice President, Advanced Manufacturing Technologies at US Pharmacopeia, USA | |
| 10:15 β 10:30 | Tea break and networking |
| 10:30 β 11:15 | The missing infrastructure: How pharmacy accreditation completes the innovation pathway |
| Christine Larivière, BPharm - Co-Owner & Pharmacist, Lariviere et Massicotte, Pharmaciennes, Inc., Canada | |
| Jonas Congelli, RPh - Associate Executive Director at NCODA, USA | |
| Brigitte Viel, BSc, DESS β Executive Director at RPMSQ, Canada | |
| 11:15 β 12:00 | Overview of USP Healthcare Quality and Safety Standards: Opportunities for pharmaceutical industry Innovation |
| Brian Serumaga, BPharm, MPH, PhD β Director, Personalized Medicines, US Pharmacopeia, USA | |
| 12:00 β 13:00 | Lunch break |
| 13:00 β13:45 | Addressing supply chain resilience and mitigating drug shortages |
| Dennis Hall, MBA β Vice President, Advanced Manufacturing Technologies at US Pharmacopeia, USA | |
| 13:45 β 14:30 | Panel discussion |
| 14:30 β 15:00 | Closing |
